Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

NCT00742144 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular

Interventions

DRUG: ofatumumab

Sponsor

GlaxoSmithKline